These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8726009)

  • 61. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
    Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sequential Parenteral to Oral Clindamycin Dosing in Pediatric Musculoskeletal Infection: A Retrospective Review of 30 mg/kg/d Versus 40 mg/kg/d.
    Erickson CM; Sue PK; Stewart K; Thomas MI; Lindsay EA; Jo C; Copley LA
    Pediatr Infect Dis J; 2016 Oct; 35(10):1092-6. PubMed ID: 27286561
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Prevalence of inducible clindamycin resistance in Staphylococcus aureus strains isolated from clinical samples].
    Colakoğlu S; Alişkan H; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2008 Jul; 42(3):407-12. PubMed ID: 18822883
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ; Blakemore PH
    Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ; Andes DR
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1376-83. PubMed ID: 16569855
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples.
    Deotale V; Mendiratta DK; Raut U; Narang P
    Indian J Med Microbiol; 2010; 28(2):124-6. PubMed ID: 20404457
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
    J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
    Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureus.
    Oh JT; Cassino C; Schuch R
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936103
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus.
    Aeschlimann JR; Hershberger E; Rybak MJ
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1914-8. PubMed ID: 10428912
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activity of clindamycin against Staphylococcus aureus and Staphylococcus epidermidis from four UK centres.
    Reeves DS; Holt HA; Phillips I; King A; Miles RS; Paton R; Wise R; Andrews JM
    J Antimicrob Chemother; 1991 Apr; 27(4):469-74. PubMed ID: 1856126
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The postantibiotic effect of meropenem and imipenem on selected bacteria.
    Nadler HL; Pitkin DH; Sheikh W
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants.
    Gonzalez D; Delmore P; Bloom BT; Cotten CM; Poindexter BB; McGowan E; Shattuck K; Bradford KK; Smith PB; Cohen-Wolkowiez M; Morris M; Yin W; Benjamin DK; Laughon MM
    Antimicrob Agents Chemother; 2016 May; 60(5):2888-94. PubMed ID: 26926644
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus.
    Gadepalli R; Dhawan B; Mohanty S; Kapil A; Das BK; Chaudhry R
    Indian J Med Res; 2006 Apr; 123(4):571-3. PubMed ID: 16783051
    [No Abstract]   [Full Text] [Related]  

  • 77. [Resistance of Staphylococcus aureus isolated from burn wounds to antibiotics].
    Grigaite R; Pavilonis A; Rimdeika R; Antusevas A
    Medicina (Kaunas); 2006; 42(5):377-83. PubMed ID: 16778465
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro postantibiotic effect of roxithromycin and erythromycin against gram-positive cocci.
    Chang JC; Hsueh PR; Young C
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):276-84. PubMed ID: 1342645
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.
    Bouazza N; Pestre V; Jullien V; Curis E; Urien S; Salmon D; Tréluyer JM
    Br J Clin Pharmacol; 2012 Dec; 74(6):971-7. PubMed ID: 22486719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antivirulence potential of TR-700 and clindamycin on clinical isolates of Staphylococcus aureus producing phenol-soluble modulins.
    Yamaki J; Synold T; Wong-Beringer A
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4432-5. PubMed ID: 21670179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.